SCHEMBL17764426

SCHEMBL17764426

CCc1ccc(NC(=O)c2cc(NCC3CCCO3)cc(-c3cc(F)cc(CNC(=O)OC(C)(C)C)c3)c2)c(CC(=O)O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ SUCNR1 Q9BXA5 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ ALDH1A1 P00352 6/20 0.35
▸ ALOX12 P18054 2/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ ATM Q13315 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HPGD P15428 3/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ PDK1 Q15118 1/20 0.34
▸ PDK2 Q15119 1/20 0.34
▸ PDK3 Q15120 1/20 0.34
▸ PDK4 Q16654 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410364 0.95 MAPT (0.37) MAPTKMT2AHDAC1LMNANPC1
SCHEMBL16410456 0.87 SMN1; SMN2 (0.38) MAPTKMT2ASUCNR1LMNANPC1
SCHEMBL17764431 0.82 HDAC1 (0.45) MAPTKMT2AHDAC1SUCNR1L3MBTL1
SCHEMBL17764497 0.81 SUCNR1 (0.52) HDAC1SUCNR1
SCHEMBL17764302 0.80 SUCNR1 (0.43) MAPTHDAC1SUCNR1LMNANPC1
SCHEMBL17764531 0.77 CFD (0.49) KMT2ASUCNR1LMNANPC1RAB9A
SCHEMBL16410291 0.77 CFD (0.49) KMT2ASUCNR1LMNANPC1RAB9A
SCHEMBL17764307 0.77 CFD (0.49) KMT2ASUCNR1LMNANPC1RAB9A
SCHEMBL16410465 0.76 HDAC1 (0.41) MAPTKMT2AHDAC1SUCNR1L3MBTL1
SCHEMBL16409648 0.75 HDAC1 (0.47) MAPTHDAC1SUCNR1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160145247-A1 Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof NOVARTIS AG (CH) 2016-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160145247-A1 Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof CFD, CFH, CFB MAPT 3865/4885KMT2A 1918/4885HDAC1 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback